Transcend Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
11,347
+2,638
| +30% | +$283K | 0.09% | 193 |
|
|
2025
Q1 | $879K | Buy |
8,709
+1,275
| +17% | +$129K | 0.06% | 272 |
|
|
2024
Q4 | $664K | Buy |
7,434
+271
| +4% | +$24.2K | 0.05% | 298 |
|
|
2024
Q3 | $600K | Buy |
7,163
+390
| +6% | +$32.7K | 0.04% | 350 |
|
|
2024
Q2 | $522K | Buy |
6,773
+148
| +2% | +$11.4K | 0.04% | 346 |
|
|
2024
Q1 | $454K | Sell |
6,625
-6,627
| -50% | -$454K | 0.04% | 346 |
|
|
2023
Q4 | $766K | Buy |
13,252
+1,084
| +9% | +$62.7K | 0.07% | 248 |
|
|
2023
Q3 | $642K | Sell |
12,168
-157
| -1% | -$8.29K | 0.06% | 257 |
|
|
2023
Q2 | $667K | Buy |
12,325
+7,956
| +182% | +$430K | 0.06% | 258 |
|
|
2023
Q1 | $219K | Sell |
4,369
-945
| -18% | -$47.3K | 0.02% | 431 |
|
|
2022
Q4 | $246K | Buy |
+5,314
| New | +$246K | 0.03% | 403 |
|
|
2022
Q2 | – | Sell |
-5,583
| Closed | -$247K | – | 501 |
|
|
2022
Q1 | $247K | Buy |
+5,583
| New | +$247K | 0.02% | 433 |
|